SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIROCYCLOPROPANE-1,3'- INDOLIN-2'-ONES

摘要

The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.